Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

A 70-year-old man has renal failure, hypercalcemia, and lytic bone lesions. Serum protein electrophoresis shows an M-spike in the gamma region. Which mechanism accounts for bone destruction in multiple myeloma?

  • A Direct invasion by myeloma cells into cortical bone
  • B Ectopic PTH secretion by myeloma cells causing generalized osteoclast activation
  • C Myeloma cells secrete RANKL and DKK1, activating osteoclasts and inhibiting osteoblasts
  • D IL-6 directly dissolves hydroxyapatite crystals
Correct answer: C. Myeloma cells secrete RANKL and DKK1, activating osteoclasts and inhibiting osteoblasts

Explanation

Myeloma cells and stromal cells produce RANKL (receptor activator of NF-κB ligand) which drives osteoclast differentiation and activity, creating lytic lesions. Simultaneously, DKK1 (Dickkopf-1) secreted by myeloma cells inhibits the Wnt pathway, suppressing osteoblast activity and preventing bone repair. This uncoupling explains purely lytic lesions without reactive sclerosis. PTH is not secreted by myeloma cells.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →